Photoimmunotherapy (PIT) Phase 2 Study: Multicenter, Open-Label, Study Of RM-1929 Photoimmunotherapy (PIT) In Patients With Locoregional, Recurrent Head & amp; Neck Squamous Cell Carcinoma (rHNSCC)

David M. Cognetti MD @KimmelCancerCtr Of Sidney Kimmel Cancer Center Discusses Photoimmunotherapy (PIT) Phase 2 Study: Multicenter, Open-Label, Study Of RM-1929 Photoimmunotherapy (PIT) In Patients Wi... Author: Annual-Meeting Added: 06/01/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts